menu search

Theriva Biologics Reports First Quarter 2023 Operational Highlights and Financial Results

Theriva Biologics Reports First Quarter 2023 Operational Highlights and Financial Results
– Continued to enroll patients in VIRAGE, the Phase 2b clinical trial of systemically administered VCN-01 in combination with chemotherapy for Pancreatic Ductal Adenocarcinoma – – Presented data from the ongoing Phase 1b/2a clinical trial of SYN-004 (ribaxamase) in allogeneic hematopoietic cell transplant recipients at the 33rd European Congress of Clinical Microbiology & Infectious Disease; Cohort […] The post Theriva Biologics Reports First Quarter 2023 Operational Highlights and Financial Res... Read More
Posted: May 11 2023, 12:00
Author Name: forextv
Views: 081780

Search within

Pages Search Results: